Journals / Anadolu Kardiyoloji Dergisi / 2011 / Cilt: 11 - Sayı: 5

QT interval prolongation due to metronidazole administration

Metronidazol uygulamasına bağlı QT uzaması

Pages
468–469
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

KANYILMAZ, S., ALTIN, C., ÖZİN, B., BAYSAL, S. (2022). QT interval prolongation due to metronidazole administration. Anadolu Kardiyoloji Dergisi, Cilt: 11 - Sayı: 5, 468–469. https://ajindex.com/articles/436566

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Viskin S, Justo D, Halkin A, Zeltser D. Long QT syndrome caused by noncardiac drugs. Prog Cardiovasc Dis 2003; 45: 415-27
  2. Justo D, Zeltser D. Torsade de pointes induced by systemic antifungal agents: lessons from a retrospective analysis of published case reports. Mycoses 2006; 49: 463-70
  3. Stedman CA, Barclay ML. Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Aliment Pharmacol Ther 2000; 14: 963-78
  4. Kounas SP, Letsas KP, Sideris A, Efraimidis M, Kardaras F. QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone. Pacing Clin Electrophysiol 2005; 28: 472-3
  5. Cohen O, Saar N, Swartzon M, Kliuk-Ben-Bassat O, Justo D. First report of metronidazole-induced QT interval prolongation. Int J Antimicrob Agents 2008; 31: 180-1.